These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29581299)

  • 1. MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.
    Huang Q; Chen L; Yang L; Xie X; Gan L; Cleveland JL; Chen J
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3368-E3377. PubMed ID: 29581299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding.
    Wu S; Chen L; Becker A; Schonbrunn E; Chen J
    Mol Cell Biol; 2012 Dec; 32(23):4821-32. PubMed ID: 23028042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoinhibition of MDMX by intramolecular p53 mimicry.
    Chen L; Borcherds W; Wu S; Becker A; Schonbrunn E; Daughdrill GW; Chen J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4624-9. PubMed ID: 25825738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
    Wei X; Wu S; Song T; Chen L; Gao M; Borcherds W; Daughdrill GW; Chen J
    Proc Natl Acad Sci U S A; 2016 May; 113(19):E2558-63. PubMed ID: 27114532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of MdmX as a therapeutic target for reactivating p53 in tumors.
    Garcia D; Warr MR; Martins CP; Brown Swigart L; Passegué E; Evan GI
    Genes Dev; 2011 Aug; 25(16):1746-57. PubMed ID: 21852537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors.
    Chen R; Zhou J; Qin L; Chen Y; Huang Y; Liu H; Su Z
    Biochemistry; 2017 Jun; 56(25):3273-3282. PubMed ID: 28581721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MdmX regulates transformation and chromosomal stability in p53-deficient cells.
    Matijasevic Z; Krzywicka-Racka A; Sluder G; Jones SN
    Cell Cycle; 2008 Oct; 7(19):2967-73. PubMed ID: 18818521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MDMX Acidic Domain Uses Allovalency to Bind Both p53 and MDMX.
    Fenton M; Borcherds W; Chen L; Anbanandam A; Levy R; Chen J; Daughdrill G
    J Mol Biol; 2022 Nov; 434(22):167844. PubMed ID: 36181774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A site-directed mutagenesis study of the MdmX RING domain.
    Egorova O; Mis M; Sheng Y
    Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MDMX acidic domain competes with the p53 transactivation domain for MDM2 N-terminal domain binding.
    Song Q; Liu XQ; Rainey JK
    Biochim Biophys Acta Mol Cell Res; 2022 Oct; 1869(10):119319. PubMed ID: 35780910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
    Qin L; Yang F; Zhou C; Chen Y; Zhang H; Su Z
    J Am Chem Soc; 2014 Dec; 136(52):18023-33. PubMed ID: 25453499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
    Linke K; Mace PD; Smith CA; Vaux DL; Silke J; Day CL
    Cell Death Differ; 2008 May; 15(5):841-8. PubMed ID: 18219319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX.
    Levy R; Gregory E; Borcherds W; Daughdrill G
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30832340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.
    Biderman L; Poyurovsky MV; Assia Y; Manley JL; Prives C
    Mol Cell Biol; 2012 Apr; 32(7):1214-25. PubMed ID: 22290440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization.
    Leslie PL; Ke H; Zhang Y
    J Biol Chem; 2015 May; 290(20):12941-50. PubMed ID: 25809483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner.
    Zhang Y; Zeng SX; Hao Q; Lu H
    Dev Biol; 2017 Mar; 423(1):34-45. PubMed ID: 28118981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p53-MDMX interaction by casein kinase 1 alpha.
    Chen L; Li C; Pan Y; Chen J
    Mol Cell Biol; 2005 Aug; 25(15):6509-20. PubMed ID: 16024788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of CCDC106 regulating the p53-Mdm2/MdmX signaling axis.
    Zhou T; Ke Z; Ma Q; Xiang J; Gao M; Huang Y; Cheng X; Su Z
    Sci Rep; 2023 Dec; 13(1):21892. PubMed ID: 38081879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.